Ray Dalio's position in Bristol-Myers Squibb is currently worth $126M. That's 0.49% of their equity portfolio (49th largest holding). The first Bristol-Myers Squibb trade was made in Q4 2005. Since then Ray Dalio bought shares 38 more times and sold shares on 23 occasions. The investor's estimated purchase price is $161M, resulting in a loss of 22%.